Unknown

Dataset Information

0

Modeling and experimental analyses reveals signaling plasticity in a bi-modular assembly of CD40 receptor activated kinases.


ABSTRACT: Depending on the strength of signal dose, CD40 receptor (CD40) controls ERK-1/2 and p38MAPK activation. At low signal dose, ERK-1/2 is maximally phosphorylated but p38MAPK is minimally phosphorylated; as the signal dose increases, ERK-1/2 phosphorylation is reduced whereas p38MAPK phosphorylation is reciprocally enhanced. The mechanism of reciprocal activation of these two MAPKs remains un-elucidated. Here, our computational model, coupled to experimental perturbations, shows that the observed reciprocity is a system-level behavior of an assembly of kinases arranged in two modules. Experimental perturbations with kinase inhibitors suggest that a minimum of two trans-modular negative feedback loops are required to reproduce the experimentally observed reciprocity. The bi-modular architecture of the signaling pathways endows the system with an inherent plasticity which is further expressed in the skewing of the CD40-induced productions of IL-10 and IL-12, the respective anti-inflammatory and pro-inflammatory cytokines. Targeting the plasticity of CD40 signaling significantly reduces Leishmania major infection in a susceptible mouse strain. Thus, for the first time, using CD40 signaling as a model, we show how a bi-modular assembly of kinases imposes reciprocity to a receptor signaling. The findings unravel that the signalling plasticity is inherent to a reciprocal system and that the principle can be used for designing a therapy.

SUBMITTER: Sarma U 

PROVIDER: S-EPMC3399835 | biostudies-literature | 2012

REPOSITORIES: biostudies-literature

altmetric image

Publications

Modeling and experimental analyses reveals signaling plasticity in a bi-modular assembly of CD40 receptor activated kinases.

Sarma Uddipan U   Sareen Archana A   Maiti Moitrayee M   Kamat Vanita V   Sudan Raki R   Pahari Sushmita S   Srivastava Neetu N   Roy Somenath S   Sinha Sitabhra S   Ghosh Indira I   Chande Ajit G AG   Mukhopadhyaya Robin R   Saha Bhaskar B  

PloS one 20120718 7


Depending on the strength of signal dose, CD40 receptor (CD40) controls ERK-1/2 and p38MAPK activation. At low signal dose, ERK-1/2 is maximally phosphorylated but p38MAPK is minimally phosphorylated; as the signal dose increases, ERK-1/2 phosphorylation is reduced whereas p38MAPK phosphorylation is reciprocally enhanced. The mechanism of reciprocal activation of these two MAPKs remains un-elucidated. Here, our computational model, coupled to experimental perturbations, shows that the observed r  ...[more]

Similar Datasets

| S-EPMC6519352 | biostudies-literature
| S-EPMC2132449 | biostudies-literature
| S-EPMC2647835 | biostudies-other
| S-EPMC3571867 | biostudies-other
| S-EPMC5902510 | biostudies-literature
| S-EPMC7418108 | biostudies-literature
| S-EPMC3632113 | biostudies-literature
| S-EPMC1885963 | biostudies-literature
| S-EPMC4968401 | biostudies-literature
| S-EPMC3049208 | biostudies-literature